| Altered cancer metabolism in mechanisms of immunotherapy resistance R Ramapriyan, MS Caetano, HB Barsoumian, ACP Mafra, EP Zambalde, ... Pharmacology & therapeutics 195, 162-171, 2019 | 132 | 2019 |
| Long non‐coding RNAs in cancer: another layer of complexity JC de Oliveira, LC Oliveira, C Mathias, GA Pedroso, DS Lemos, ... The journal of gene medicine 21 (1), e3065, 2019 | 111 | 2019 |
| Long non-coding RNAs in multifactorial diseases: another layer of complexity GA Cipolla, JC De Oliveira, A Salviano-Silva, SC Lobo-Alves, DS Lemos, ... Non-coding RNA 4 (2), 13, 2018 | 75 | 2018 |
| Long non‐coding RNAs differential expression in breast cancer subtypes: what do we know? C Mathias, EP Zambalde, P Rask, DF Gradia, JC de Oliveira Clinical genetics 95 (5), 558-568, 2019 | 45 | 2019 |
| The modulatory role of MicroRNA-873 in the progression of KRAS-driven cancers HA Mokhlis, R Bayraktar, NN Kabil, A Caner, N Kahraman, ... Molecular Therapy-Nucleic Acids 14, 301-317, 2019 | 30 | 2019 |
| The anti-inflammatory and pro-resolution effects of aspirin-triggered RvD1 (AT-RvD1) on peripheral blood mononuclear cells from patients with severe asthma ÉP Zambalde, MM Teixeira, DC Favarin, JR de Oliveira, ML Magalhães, ... International immunopharmacology 35, 142-148, 2016 | 24 | 2016 |
| Highlighting transcribed ultraconserved regions in human diseases E Pereira Zambalde, C Mathias, AC Rodrigues, ... Wiley Interdisciplinary Reviews: RNA 11 (2), e1567, 2020 | 22 | 2020 |
| A novel lncRNA derived from an ultraconserved region: lnc-uc.147, a potential biomarker in luminal A breast cancer E Pereira Zambalde, R Bayraktar, T Schultz Jucoski, C Ivan, ... RNA biology 18 (sup1), 416-429, 2021 | 12 | 2021 |
| Knockout of NRF2 triggers prostate cancer cells death through ROS modulation and sensitizes to cisplatin MCS Mancini, AP Morelli, MB Severino, ICB Pavan, ÉP Zambalde, ... Journal of Cellular Biochemistry 123 (12), 2079-2092, 2022 | 10 | 2022 |
| lncRNAs in hallmarks of cancer and clinical applications L Garcia, E Zambalde, C Mathias, J Barazetti, D Gradia, J Oliveira Non-Coding RNAs, 2019 | 9 | 2019 |
| Long noncoding RNAs in multifactorial diseases: another layer of complexity. Non-Coding RNA 4: 13 GA Cipolla, JC de Oliveira, A Salviano-Silva, SC Lobo-Alves, DS Lemos, ... | 9 | 2018 |
| Characterization of the interaction between SARS-CoV-2 membrane protein (M) and proliferating cell nuclear antigen (PCNA) as a potential therapeutic target ÉP Zambalde, ICB Pavan, MCS Mancini, MB Severino, OB Scudero, ... Frontiers in Cellular and Infection Microbiology 12, 849017, 2022 | 8 | 2022 |
| Novel lncRNAs co-expression networks identifies LINC00504 with oncogenic role in luminal A breast cancer cells C Mathias, CS Groeneveld, S Trefflich, EP Zambalde, RS Lima, CA Urban, ... International Journal of Molecular Sciences 22 (5), 2420, 2021 | 5 | 2021 |
| Lnc-uc. 147 is associated with disease stage of liver, gastric, and renal cancer AC Rodrigues, EP Zambalde, DL Bellan, ES Trindade, EMSF Ribeiro, ... Biomolecules 13 (2), 265, 2023 | 4 | 2023 |
| Increased mTOR signaling and impaired autophagic flux are hallmarks of SARS-CoV-2 infection ÉP Zambalde, TL Dias, GC Maktura, MR Amorim, B Brenha, LN Santos, ... Current Issues in Molecular Biology 45 (1), 327-336, 2022 | 4 | 2022 |
| Transcribed ultraconserved regions are associated with clinicopathological features in breast cancer EP Zambalde, D Adamoski, DF Gradia, I Rabinovich, AC Rodrigues, ... Biomolecules 12 (2), 214, 2022 | 3 | 2022 |
| The Potential of NORAD–PUMILIO–RALGAPB Regulatory Axis as a Biomarker in Breast Cancer CSM Muller, IS Giner, ÉP Zambalde, TM Carvalho, EMSF Ribeiro, ... Non-coding RNA 8 (6), 76, 2022 | 1 | 2022 |
| Regulation of Immune Cells by microRNAs and microRNA-Based Cancer Immunotherapy RN Veiga, ÉP Zambalde, L Cox, TS Jucoski, AF Kohler, TM Carvalho, ... Systems Biology of MicroRNAs in Cancer, 75-108, 2022 | 1 | 2022 |
| Resistance exercise attenuates IKKε phosphorylation and hepatic fat accumulation of obese mice GC Antunes, RD de Lima, RFL Vieira, APA Macêdo, VR Muñoz, ... Clinical and Experimental Pharmacology and Physiology 49 (10), 1072-1081, 2022 | | 2022 |
| Increased mTOR signaling, impaired autophagic flux and cell-to-cell viral transmission are hallmarks of SARS-CoV-2 infection GC Maktura, TL Dias, ÉP Zambalde, B Brenha, MR Amorim, LN Santos, ... bioRxiv, 2021.10. 13.464225, 2021 | | 2021 |
Daniela GradiaUniversidade Federal do Paraná在 pq.cnpq.br 的电子邮件经过验证
